Withdrawal from the market of BS-MTI ureteral stent sets with EPflex guidewire
The manufacturer BS Medical Tech Industry is withdrawing from the market and from use all batches of more than a dozen ureteral and nephrostomy stent sets that include the EPflex guidewire.

© Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych
- 0views
- 0likes and saves
- 0skips
In brief
- The manufacturer BS Medical Tech Industry has withdrawn from the market and from use all series of ureteral and nephrostomy stent sets containing the EPflex guidewire.
- The reason is the withdrawal of this guidewire by the manufacturer of EPflex.
- The affected sets include, among others, Innoflex, Innosoft, Innostar, Percudrain, Percusoft and Balloon 2 step Nephrostomy.
- The sets must no longer be used or placed on the market.
Reason for the withdrawal
According to the safety notice, the decision was made because the manufacturer of EPflex withdrew from the market and from use the guidewire contained in the kits listed (Notatka bezpieczeństwa (FSCA-BSMTI-26001-Rev00) firmy BS Medical Tech Industry (BS-MTI) dotycząca wycofania z obrotu i z użytku wszystkich serii zestawów stentów moczowodowych: (Zestaw) IMP Tumorstent, (Zestaw) Innoflex Mono-J, (Zestaw) Innoflex Ureteral stent, (Zestaw) Innosoft Mono-J, (Zestaw) Innosoft Ureteralstent, (Zestaw) Innostar Ureteralstent, (Zestaw) Percudrain 2 step nephrostomy, (Zestaw) Percudrain 3, (Zestaw) Percusoft 3 step drainage, (Zestaw) Percusoft 3 step nephrostomy set, Ba – Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych). The restriction covers all product series in which this guidewire was used.
Products covered by the decision
The withdrawal covers the following sets: IMP Tumorstent, Innoflex Mono-J, Innoflex Ureteral stent, Innosoft Mono-J, Innosoft Ureteralstent, Innostar Ureteralstent, Percudrain 2 step nephrostomy, Percudrain 3, Percusoft 3 step drainage, Percusoft 3 step nephrostomy set and Balloon 2 step Nephrostomy. It applies to all their series, not selected lots.
What happens next with the sets
The sets should no longer be used or placed on the market. The safety document, marked with the number FSCA-BSMTI-26001-Rev00, was published by the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products. Hospitals and facilities holding these products should, according to the notice, suspend their use and follow further instructions from the manufacturer and the office.
Who this concerns
This primarily concerns medical facilities that perform urological procedures using ureteral stents and nephrostomy. Patients who had such devices implanted should talk to their treating physician if they have questions about their situation. The material does not contain information on the number of patients at risk or on specific health consequences.
Read also
- Stryker Spine wycofuje 51 serii systemu kręgosłupowego ES2 Nitinol z tępym drutem Kirschnera
Sources
Discussion0
- No comments from this perspective yet. Be the first.